Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest sepsis Stories

2010-01-11 12:23:00

MIAMI, Jan. 11, 2010 /PRNewswire-FirstCall/ -- Severe sepsis is a leading cause of death in intensive care units. According to the Society of Critical Care Medicine (SCCM), severe sepsis strikes an estimated 750,000 people in the United States each year. Consistent with its ongoing commitment to early intervention and improved patient outcomes, Banner Health worked with Royal Philips Electronics (NYSE: PHG, AEX: PHI) to implement the Philips VISICU eICU® Sepsis...

2010-01-11 08:00:00

DURHAM, N.C., Jan. 11 /PRNewswire/ -- bioMerieux, a world leader in the field of in vitro diagnostics, today released its results of a comprehensive survey of emergency department and critical care physicians. The vast majority of these doctors reported that sepsis and septic shock--the result of serious infections--is on the rise in U.S. hospitals, affecting increasingly younger patients. The surveyed doctors attributed the increase to the overuse of antibiotics, which is rendering these...

2009-12-22 08:00:00

WOODCLIFF LAKE, N.J., Dec. 22 /PRNewswire/ -- The investigational compound, eritoran tetrasodium ("eritoran," also known as E5564) appeared to be well tolerated in patients with severe sepsis in a Phase II trial published in the January issue of Critical Care Medicine, the official journal of the Society of Critical Care Medicine, the largest multiprofessional organization dedicated to ensuring excellence and consistency in the practice of critical care. The trial evaluated two doses of...

2009-12-21 15:32:15

Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus. The findings,...

2009-12-17 17:50:00

Toronto Stock Exchange Symbol: MS EDMONTON, Dec. 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS) today provided the following update on corporate developments: Dirucotide Update ----------------- The Company has completed its substantive review of the data from the discontinued late-stage trials for dirucotide, its drug candidate for the treatment of multiple sclerosis (MS). BioMS has decided that it will explore a compassionate access and research program with limited...

2009-12-17 17:45:00

- BioMS Medical makes strategic investment of $12 million in Spectral - TORONTO and EDMONTON, Dec. 17 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX: SDI) and BioMS Medical Corp. (TSX: MS) today announced that BioMS Medical ("BioMS") and a syndicate of investors have invested $14 million in Spectral Diagnostics ("Spectral", or the "Company") to advance Toraymyxin(TM), a treatment for severe sepsis, towards regulatory approval and commercialization in the United States. Spectral...

2009-12-15 21:55:06

Scientists at VIB and Ghent University in Flanders, Belgium have found an unexpected ally for the treatment of septic shock, the major cause of death in intensive care units. By inducing the release of nitric oxide (NO) gas in mice with septic shock, researchers Anje Cauwels and Peter Brouckaert discovered that the animal's organs showed much less damage, while their chances of survival increased significantly. That's contrary to all expectations, since it is generally assumed that nitric...

2009-12-02 09:00:00

DENVER, Dec. 2 /PRNewswire/ -- Medical Simulation Corporation (MSC) will highlight its full menu of Quality Initiative Programs at the 2009 IHI National Forum, December 7-9, 2009, in Orlando, Florida. MSC is the first simulation company to introduce simulation-based education programs that help healthcare providers bridge the gap between measurement and achievement of publicly reported patient safety and quality initiatives. MSC's Sepsis, Ventilator-Associated Pneumonia and Central Line...

2da7bdf1a682eba84c9ccbf7c6baa2a4
2009-12-02 11:00:00

Nearly half of patients in intensive care units globally contract infections, and 70 percent are being treated with antibiotics, a development that may aid the rise of drug-resistant viruses, researchers announced Tuesday. Patients who contracted infections were more likely to not survive, specifically if they become septic, a survey of 13,000 patients noted. Still, a major concern that remains is over-prescription of antibiotics in patients without infections, which can lead to antibiotic...

2009-11-05 13:09:33

Patients experiencing septic shock who receive inappropriate therapy may have a fivefold reduction in survival, shows a new study. Researchers from the University of Manitoba, Winnipeg, MB, Canada, retrospectively reviewed the cases of 5,715 patients with septic shock to determine the appropriateness of initial antimicrobial therapy, clinical infection site, and relevant pathogens. Results showed that inappropriate initial antimicrobial therapy occurred in 20 percent of patients, and the...


Latest sepsis Reference Libraries

0_cef863082995e6cb66fa4a692bf165a7
2011-04-28 16:37:36

Vibrio vulnificus is a species of Gram-negative, motile, curved, rod-shaped bacteria of the Vibrio Genus. Hollis et al. first reported it in 1976. It was given the name Beneckea vulnifica by Reichelt et al. in 1976 and in 1979 Vibrio vulnificus by Farmer. V. vulnificus is related to V. cholerae and is present in marine environments such as estuaries, brackish ponds, or coastal areas. It causes an infection often incurred after eating seafood, especially raw or undercooked oysters. It can...

More Articles (1 articles) »